期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(18)F-FDG PET/CT显像SUV与鼻咽癌预后的关系 被引量：3

下载PDF
导出
摘要 目前关于PET／CT对鼻咽癌（NPC）诊断、分期和判断预后等方面的研究较多，然而鲜有报道其SUV与预后的关系，笔者现就此报道如下。
作者 孟雪 刘希军 于金明 付政 杨国仁 韩安勤 孙新东 孔莉 郑劲松
机构地区 山东省肿瘤医院放疗二科 山东省肿瘤医院PET/CT中心
出处 《中华核医学杂志》 CAS CSCD 北大核心 2007年第3期183-183,共1页 Chinese Journal of Nuclear Medicine
关键词 PET/CT显像 判断预后 鼻咽癌
分类号 R739.63 [医药卫生—肿瘤]
  • 相关文献

参考文献4

二级参考文献44

  • 1Ahuja V, Coleman RE, Herndon J, et al.Prognostic significance of FDG-PET imaging in patients with non-small cell lung cancer. Cancer, 1998, 83: 918-924.
  • 2Kubota K, Tada M, Yamada S, et al. Comparison of the distribution of 18F-fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med, 1999, 26: 750-757.
  • 3Koh WJ, Bergman KS, Rasey JS, et al. Evaluation of oxygenation status during fractionated radiotherapy in human non-small cell lung cancers using 18F-fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys,1998, 33: 391-398.
  • 4Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of 18F-fluoromisonidazole: a pretherapy study of 37 patients.Int J Radiat Oncol Biol Phys, 1996, 36: 417-428.
  • 5Lehtio K, Oikonen V, Nyman S, et al. Quantifying tumor hypoxia with 18F-fluoroerythronitroimidazole (18 F-FETNIM) and PET using the tumor to plasma ratio. Eur J Nucl Med Mol Imaging, 2003, 30: 101-108.
  • 6Takahashi N, Fujibayashi Y, Yonekura Y, et al.Evaluation of 62Cu labeled diacetyl-bis ( N-4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann Nucl Med, 2000, 14: 323-328.
  • 7Siim BG, Laux WT, Rutland MD, et al. Scintigraphic imaging of the hypoxia marker 99 Tcm-labeled 2,2'- ( 1,4-diaminobutane ) bis (2-methyl-3-butanone) dioxime (99Tcm labeled HL91; Prognox): non-invasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Res, 2000, 60: 4582-4588.
  • 8Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance:Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys, 2001,49: 1171-1182.
  • 9Haberkom U, Strauss LG, Dimitrakopoulou A,et al. PET studies for fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med,2001, 32:1485-1490.
  • 10Erdi YE, Macapinlac H, Rosenzweig KE, et al.Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med,2000, 27: 861-866.

共引文献35

同被引文献54

  • 1刘泰福,徐国镇.全国鼻咽癌会议纪要[J].中华放射肿瘤学杂志,1992,0(4):5-10. 被引量：132
  • 2Yu HM,Liu YF,Hou M,et al.Evaluation of gross tumor size using CT,18F-FDG PET,integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer[J].Euro J Radio,2009,72(1):104-113.
  • 3Arie G,Avishay G,Marcello D,et al.Fluorine-18fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx:diagnostic accuracy and impact on clinical management[J].Int J Radiation Oncology Biol Phys,2007,68(2):370-376.
  • 4Antoch G,Vogt FM,Freudenberg LS,et al.Wholebody dual-modality PET/CT and whole-body MRI for tumnor staging in oncology[J].JAMA,2003,290(24):3199-3206.
  • 5Chan SC,Chang JT,Wang HM,et al.Prediction for distant failure in patients with stage MO nasopharyngeal carcinoma:The role of standardized uptake value[J].Oral Oncol,2009,45(1):52-58.
  • 6Song YS,Lee WW,Chung JH,et al.Correlation between FDG uptake and glucose transporter type 1expression in neuroendocrine tumors of the lung[J].Lung Cancer,2008,61:54-60.
  • 7Chung JK,Lee Y J,Kim C,et al.Mechanisms related to[18F] fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice[J].J Nucl Med,1999,40(2):339-346.
  • 8Li M,Liu N,Hu M,et al.Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer[J].Lung Cancer,2009,63(3):383-386.
  • 9Lee SW,Nam SY,Im KC,et al.Prediction of prognosis using standardized uptake value of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography for nasopharyngeal carcinomas[J].Radiotherapy and Oncology,2008,87(2):211-216.
  • 10Liao CT,Chang JT,Wang HM,et al.Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes[J].Int J Radiat Oncol Biol Phys,2009,73(3):764-771.

引证文献3

二级引证文献15

中华核医学杂志
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部